Regarding the rationale for combining apatinib with ICIs, it is reported that VEGF could induce the exhaustion of CD8+ cytotoxic T cells to suppress anti-tumor immunity (Kim et al. 2019). This evidence concerns the gene CD8A and neoplasm.